-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Wave Life Sciences with Buy Rating, Announces Price Target of $11

Benzinga·10/15/2026 21:56:15
语音播报
UBS analyst Joon Lee initiates coverage on Wave Life Sciences (NASDAQ:WVE) with a Buy rating and announces Price Target of $11.